Induced Pluripotent Stem Cells Production Market Size, Share, Growth, and Industry Analysis, By Types (Manual iPSC Production Process, Automated iPSC Production Process, ), By Applications (Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, Others, ) , and Regional Insights and Forecast to 2035

Last Updated: 17-July-2026
Base Year: 2025
Historical Data: 2021-2024

Region: Global
Format: PDF
Report ID: GGI125143
SKU ID: 30551697
Pages: 113

Download FREE Sample

Buy Now

1000+

GLOBAL LEADERS TRUST US

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Induced Pluripotent Stem Cells Production Market Size

1.3 Market Segmentation

1.4 Regulatory Environment

2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Induced Pluripotent Stem Cells Production Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Induced Pluripotent Stem Cells Production Business Mode and Production Process

2.3.1 Induced Pluripotent Stem Cells Production Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Induced Pluripotent Stem Cells Production Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Induced Pluripotent Stem Cells Production

2.4.2 Raw Material Cost of Induced Pluripotent Stem Cells Production

2.4.3 Labor Cost of Induced Pluripotent Stem Cells Production

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis

3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape

4.1 Global Induced Pluripotent Stem Cells Production Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Induced Pluripotent Stem Cells Production Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Induced Pluripotent Stem Cells Production Price by Manufacturer (2021-2026)

4.4 Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Product Offered and Application

4.7 Induced Pluripotent Stem Cells Production Market Competitive Situation and Trends

4.7.1 Induced Pluripotent Stem Cells Production Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Induced Pluripotent Stem Cells Production Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Induced Pluripotent Stem Cells Production Market Historical Development by Geographic Region (2021-2026)

5.1 Global Induced Pluripotent Stem Cells Production Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Induced Pluripotent Stem Cells Production Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Induced Pluripotent Stem Cells Production Market Status by Country (2021-2026)

5.3.1 North America Induced Pluripotent Stem Cells Production Sales Volume by Country (2021-2026)

5.3.2 North America Induced Pluripotent Stem Cells Production Revenue by Country (2021-2026)

5.3.3 United States Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Induced Pluripotent Stem Cells Production Market Status by Country (2021-2026)

5.4.1 Europe Induced Pluripotent Stem Cells Production Sales Volume by Country (2021-2026)

5.4.2 Europe Induced Pluripotent Stem Cells Production Revenue by Country (2021-2026)

5.4.3 Germany Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Induced Pluripotent Stem Cells Production Market Status by Country (2021-2026)

5.5.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Country (2021-2026)

5.5.3 China Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Induced Pluripotent Stem Cells Production Market Status by Country (2021-2026)

5.6.1 Latin America Induced Pluripotent Stem Cells Production Sales Volume by Country (2021-2026)

5.6.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2021-2026)

5.6.3 Mexico Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Induced Pluripotent Stem Cells Production Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2021-2026)

5.7.3 GCC Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Induced Pluripotent Stem Cells Production Sales Volume, Revenue and Growth (2021-2026)

6 Global Induced Pluripotent Stem Cells Production Market Historical Development by Product Type (2021-2026)

6.1 Induced Pluripotent Stem Cells Production Definition by Type

6.2 Global Induced Pluripotent Stem Cells Production Historical Sales Volume by Product Type (2021-2026)

6.3 Global Induced Pluripotent Stem Cells Production Historical Revenue by Product Type (2021-2026)

6.4 Global Induced Pluripotent Stem Cells Production Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Manual iPSC Production Process (2021-2026)

6.5.2 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Automated iPSC Production Process (2021-2026)

7 Global Induced Pluripotent Stem Cells Production Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Induced Pluripotent Stem Cells Production Historical Sales Volume by End User (2021-2026)

7.3 Global Induced Pluripotent Stem Cells Production Historical Revenue by End User (2021-2026)

7.4 Global Induced Pluripotent Stem Cells Production Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Drug Development & Discovery (2021-2026)

7.5.2 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Regenerative Medicine (2021-2026)

7.5.3 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Toxicology Studies (2021-2026)

7.5.4 Global Induced Pluripotent Stem Cells Production Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

8 Leading Companies Profiles

8.1 Applied StemCells, Inc.

8.1.1 Applied StemCells, Inc. Corporation Information

8.1.2 Applied StemCells, Inc. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.1.3 Applied StemCells, Inc. Performance Analysis (2021-2026)

8.1.4 Applied StemCells, Inc. Business and Markets Served

8.1.5 Applied StemCells, Inc. Recent Developments

8.2 Evotec

8.2.1 Evotec Corporation Information

8.2.2 Evotec - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.2.3 Evotec Performance Analysis (2021-2026)

8.2.4 Evotec Business and Markets Served

8.2.5 Evotec Recent Developments

8.3 Thermo Fisher Scientific, Inc.

8.3.1 Thermo Fisher Scientific, Inc. Corporation Information

8.3.2 Thermo Fisher Scientific, Inc. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.3.3 Thermo Fisher Scientific, Inc. Performance Analysis (2021-2026)

8.3.4 Thermo Fisher Scientific, Inc. Business and Markets Served

8.3.5 Thermo Fisher Scientific, Inc. Recent Developments

8.4 Fate Therapeutics

8.4.1 Fate Therapeutics Corporation Information

8.4.2 Fate Therapeutics - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.4.3 Fate Therapeutics Performance Analysis (2021-2026)

8.4.4 Fate Therapeutics Business and Markets Served

8.4.5 Fate Therapeutics Recent Developments

8.5 REPROCELL Inc.

8.5.1 REPROCELL Inc. Corporation Information

8.5.2 REPROCELL Inc. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.5.3 REPROCELL Inc. Performance Analysis (2021-2026)

8.5.4 REPROCELL Inc. Business and Markets Served

8.5.5 REPROCELL Inc. Recent Developments

8.6 Lonza

8.6.1 Lonza Corporation Information

8.6.2 Lonza - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.6.3 Lonza Performance Analysis (2021-2026)

8.6.4 Lonza Business and Markets Served

8.6.5 Lonza Recent Developments

8.7 StemCellsFactory III

8.7.1 StemCellsFactory III Corporation Information

8.7.2 StemCellsFactory III - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.7.3 StemCellsFactory III Performance Analysis (2021-2026)

8.7.4 StemCellsFactory III Business and Markets Served

8.7.5 StemCellsFactory III Recent Developments

8.8 Axol Bioscience Ltd.

8.8.1 Axol Bioscience Ltd. Corporation Information

8.8.2 Axol Bioscience Ltd. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.8.3 Axol Bioscience Ltd. Performance Analysis (2021-2026)

8.8.4 Axol Bioscience Ltd. Business and Markets Served

8.8.5 Axol Bioscience Ltd. Recent Developments

8.9 Merck KGaA

8.9.1 Merck KGaA Corporation Information

8.9.2 Merck KGaA - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.9.3 Merck KGaA Performance Analysis (2021-2026)

8.9.4 Merck KGaA Business and Markets Served

8.9.5 Merck KGaA Recent Developments

8.10 Hitachi, Ltd.

8.10.1 Hitachi, Ltd. Corporation Information

8.10.2 Hitachi, Ltd. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.10.3 Hitachi, Ltd. Performance Analysis (2021-2026)

8.10.4 Hitachi, Ltd. Business and Markets Served

8.10.5 Hitachi, Ltd. Recent Developments

8.11 REPROCELLS, Inc.

8.11.1 REPROCELLS, Inc. Corporation Information

8.11.2 REPROCELLS, Inc. - Induced Pluripotent Stem Cells Production Product Portfolio and Specification

8.11.3 REPROCELLS, Inc. Performance Analysis (2021-2026)

8.11.4 REPROCELLS, Inc. Business and Markets Served

8.11.5 REPROCELLS, Inc. Recent Developments

9 Global Induced Pluripotent Stem Cells Production Market Forecast by Product Type and End User (2026-2034)

9.1 Global Induced Pluripotent Stem Cells Production Market Forecast by Product Type (2026-2034)

9.1.1 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Manual iPSC Production Process (2026-2034)

9.1.2 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Automated iPSC Production Process (2026-2034)

9.2 Global Induced Pluripotent Stem Cells Production Market Forecast by End User (2026-2034)

9.2.1 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Drug Development & Discovery (2026-2034)

9.2.2 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Regenerative Medicine (2026-2034)

9.2.3 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Toxicology Studies (2026-2034)

9.2.4 Global Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)

10 Global Induced Pluripotent Stem Cells Production Market Forecast by Geographic Region (2026-2034)

10.1 Global Induced Pluripotent Stem Cells Production Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Induced Pluripotent Stem Cells Production Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer

Download FREE Sample

Security Code Captcha